Bill
Narcotic Drugs (Licence Charges) Bill 2016
passed, as at 2016-11-23. Health portfolio.
- Sponsor
- Not recorded
- Portfolio
- Health
Recorded stages
- introduced — 2016-09-14
- second reading — 2016-09-14
- second reading — 2016-11-07
- second reading — 2016-11-07
- third reading — 2016-11-07
- introduced — 2016-11-08
- second reading — 2016-11-08
- second reading — 2016-11-10
- second reading — 2016-11-10
- third reading — 2016-11-10
- passed — 2016-11-10
- royal assent — 2016-11-23
Divisions
No divisions recorded. Most questions are decided on the voices; this does not establish that a bill was unopposed.
Plain-language summary
Written by a model from the explanatory memorandum; not the record, as at 2016-09-14.
This bill lets the Commonwealth charge fees for licences issued under the Narcotic Drugs Act 1967.
The charge would apply to licences for medicinal cannabis, cannabis research, and manufacture, with the Commonwealth recovering costs for monitoring and compliance.
The exact charge amounts would be set in regulations, and no cost-recovery is proposed for manufacture licences at this stage.
- Introduces a licence charge for medicinal cannabis and cannabis research licences.
- Allows the Commonwealth to recover costs of administration and compliance monitoring.
- Excludes manufacture licences from the charge for now.
Holders of medicinal cannabis, cannabis research, and manufacture licences under the Narcotic Drugs Act 1967.
Sources
em
billhome
frl act